Announced Thu, 13 Nov · 15:31 IST

We have attached herewith outcome of Board Meeting. Kindly take the same on your record. Thank you.

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sonalis Consumer Products reported a strong H1 FY26 (April–September 2025), with revenue nearly doubling to Rs. 8,780.10 lakhs from Rs. 4,590.51 lakhs in H1 FY25. Profit after tax jumped to Rs. 235.80 lakhs (vs. Rs. 18.00 lakhs), and EPS rose to Rs. 4.97 from Rs. 0.90. Total assets grew to Rs. 6,595.94 lakhs, supported by a recent rights issue of 27.5 lakh shares that raised Rs. 1,501.15 lakhs. However, the company posted a negative operating cash flow of Rs. (1,494.67) lakhs, and trade receivables surged to Rs. 5,111.12 lakhs. The Board also accepted the resignation of Director Mr. Devendrakumar Viradiya effective November 6, 2025, and disclosed that part of the rights issue proceeds meant for capex (building and machinery) has been reallocated to working capital and general corporate purposes.

Likely market impact

Strong top-line growth and a sharp rise in profits are positive for shareholders, but the negative operating cash flow and ballooning receivables signal working capital stress. The reallocation of IPO/rights issue funds away from stated capex objects may raise governance concerns despite board approval, and the director departure is a minor watchpoint. Overall, the earnings beat is the headline, but cash quality and fund-use discipline warrant close attention.